Skip to main content
Clinical Trials/NCT06271174
NCT06271174
Recruiting
Phase 3

Impact Evaluation of Perioperative Locoregional Analgesia on Persistent Postoperative Pain in Children After Orthopedic Surgery for Traumatology : a Prospective, Single Center, Randomised Controlled Study.

Nantes University Hospital1 site in 1 country208 target enrollmentJune 6, 2024

Overview

Phase
Phase 3
Intervention
Carbocaine
Conditions
Persistent Postoperative Pain
Sponsor
Nantes University Hospital
Enrollment
208
Locations
1
Primary Endpoint
Persistent Postoperative Pain
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

Persistent postoperative pain is a substantial pain (scores 4-10 using a 0-10 numeric scale) that develops 3 months after surgery.

Persistent postoperative pain can be a problem even in ambulatory surgery. Loco-regional analgesia could prevent the occurrence of this pathology but contradictory results are found in ancient studies.

This study is the first randomized controlled study in children about loco-regional analgesia and persistent postoperative pain in traumatologic orthopedic surgery.

One interventional arm will receive a locoregional analgesia after general anesthesia and before incision. The other arm will only receive systemic analgesia during general anesthesia.

The incidence of persistent postoperative pain at 3, 6 and 12 months will be compared in these two groups.

The goal is to show the decrease of the incidence of the persistent postoperative pain in the group "locoregional analgesia".

Detailed Description

Patients between 5 years old and 15 years, 3 months old operated for a traumatologic orthopedic surgery in CHU Nantes will be included in this study. Patients between 5 years old and 15 years, 3 months old operated for a traumatologic orthopedic surgery in CHU Nantes will be included in this study. They will be randomized in two groups. General anesthesia will be administered in both groups. One arm will receive a locoregional analgesia guiding by echography before incision with a local anesthetic (Carbocaïne) and a systemic analgesia if necessary. One arm will only receive a systemic analgesia. The drugs used for general anesthesia and systemic analgesia will be standardized in the two groups. The incidence of persistent postoperative pain at 3, 6 and 12 months will be compared in both arms. A screening of a neuropathic pain will be realized if a pain exists. The consumption of opioids the first 24 postoperative hours, the time spent in the post interventional care unit and the incidence of nausea, vomiting will also be compared. The goal is to show the decrease of the incidence of the persistent postoperative pain and a better recovery in the post interventional care unit in the group "locoregional analgesia".

Registry
clinicaltrials.gov
Start Date
June 6, 2024
End Date
June 2026
Last Updated
last year
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Age between 5 years old and 15 years and 3 months
  • Traumatologic orthopedic surgery in CHU Nantes
  • Conscious patient (Glasgow score =15)
  • Patients able to give a verbal assessment of their pain
  • No contraindication to Locoregional Analgesia
  • Patient member of the social security system
  • Oral consent of the patient
  • Signed consent of one of the two holders of parental authority

Exclusion Criteria

  • Refusal to participate of the patient or one of the two holders of parental authority
  • Neurologic deficit of the operated limb before intervention
  • Ischemia of the operated limb before intervention
  • Polytraumatized patient
  • Allergia to Carbocaïne
  • Atrioventricular conduction disorders
  • Patient included in an other study about analgesia
  • Anticoagulant treatment
  • Uncontrolled epilepsy despite treatment
  • Porphyria

Arms & Interventions

Loco-Regional Analgesia

Patients will receive Loco-Regional Analgesia during General Anesthesia, and systemic analgesia if necessary * Carbocaine

Intervention: Carbocaine

Loco-Regional Analgesia

Patients will receive Loco-Regional Analgesia during General Anesthesia, and systemic analgesia if necessary * Carbocaine

Intervention: Profofol and/or Suxaméthonium and/or Sévoflurane

Systemic Analgesia Only

Patients will just receive General Anesthesia and systemic analgesia. _ Profofol and/or Suxaméthonium and/or Sévoflurane

Intervention: Profofol and/or Suxaméthonium and/or Sévoflurane

Outcomes

Primary Outcomes

Persistent Postoperative Pain

Time Frame: 3 months after surgery

Numerical Scale of pain superior to 3 (0 to 10). 0 : no pain - better outcome 10 : max of pain - worse outcome

Secondary Outcomes

  • Persistent postoperative pain at 12 months.(12 months after surgery.)
  • Intravenous Morphine dose received in Post Interventional Care Unit(in Post Interventional Care Unit after the surgery-)
  • Opioïd dose received - in Post Interventional Care Unit(in Post Interventional Care Unit after the surgery-)
  • Screening of neuropathic pain if persistent postoperative pain - 3 months(3 months after surgery.)
  • Screening of neuropathic pain if persistent postoperative pain - 12 months(12 months after surgery.)
  • 1st EN score in immediate post-operative ICU before morphine titration(in Post Interventional Care Unit after the surgery)
  • Persistent postoperative pain at 6 months.(6 months after surgery.)
  • Postoperative nausea and vomiting(In Post Interventional Care Unit - after the surgery-)
  • Time in Post Interventional Care Unit(In Post Interventional Care Unit - after the surgery -)
  • Opioïd dose received - Per-operative(Per-operative)
  • Opioïd dose received(during the first post-operative 24 hours in the surgery department)
  • Screening of neuropathic pain if persistent postoperative pain - 6 months(6 months after surgery.)

Study Sites (1)

Loading locations...

Similar Trials